ClinicalTrials.Veeva

Menu

Vitamin D Supplementation and Physical Function in Older Adults

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status and phase

Completed
Early Phase 1

Conditions

Physical Function
Vitamin D Insufficiency

Treatments

Dietary Supplement: Vitamin D plus calcium
Dietary Supplement: calcium

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01179503
IRB00011371
R01AG029364-03S1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

A growing body of evidence suggests that vitamin D status is important in biologic processes involved in the maintenance of physical function. To advance the investigators understanding of the role of vitamin D in physical function, the investigators will conduct a feasibility pilot study to collect key information to help design a full-scale randomized trial to determine whether vitamin D supplementation will delay declines in physical function. The primary goals of the pilot study are to determine cost-effective strategies for identifying persons at high risk for functional decline with insufficient vitamin D levels, determine the serum vitamin D response to a vitamin D supplementation regimen designed to attain sufficient vitamin D levels, and provide preliminary data of key functional measures (balance, physical performance and muscle power) for the future larger study design. A secondary goal is to begin to examine potential mechanisms by which vitamin D supplementation may enhance physical performance by exploring the effects of vitamin D supplementation on changes in skeletal muscle gene expression.

Full description

A growing body of evidence suggests that vitamin D status is important in biologic processes involved in the maintenance of physical function. However, whether remediation of vitamin D insufficiency will improve physical function and the potential mechanisms involved are unclear. Previous vitamin D supplementation trials have produced mixed results with respect to physical function; however, most trials did not specifically recruit individuals who were vitamin D insufficient nor is the potential mechanism of action understood well enough to appropriately select those individuals most likely to benefit. To advance our understanding of the role of vitamin D in physical function, the investigators will conduct a feasibility pilot study to collect key information to help design a full-scale randomized trial to determine whether vitamin D supplementation will delay declines in physical function. The primary goals of the pilot study are to determine cost-effective strategies for identifying persons at high risk for functional decline with insufficient vitamin D levels, determine the serum vitamin D response to a vitamin D supplementation regimen designed to attain sufficient vitamin D levels, and provide preliminary data of key functional measures (balance, short physical performance battery (SBBP) and muscle power) for the future larger study design. A secondary goal is to begin to examine potential mechanisms by which vitamin D supplementation may enhance physical performance and muscle contractility by exploring the effects of vitamin D supplementation on changes in skeletal muscle gene expression using microarrays.

Enrollment

16 patients

Sex

All

Ages

70 to 89 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Short Physical Performance Battery (SPPB) score of ≥ 4 to < 10
  • Vitamin D insufficient (serum 25(OH)D ≥ 10 to < 25 ng/mL)

Exclusion criteria

  • Serious or uncontrolled chronic disease including: insulin-dependent or uncontrolled diabetes; cancer requiring treatment in past year, except non-melanoma skin cancers; past or current ischemic heart disease, uncontrolled angina, heart failure, peripheral artery disease (PAD), or stroke; chronic respiratory disease; uncontrolled endocrine/metabolic disease; neurological or hematological disease; liver or renal dysfunction; and severe musculoskeletal impairment
  • Impaired cognitive function (MMSE ≤ 24)
  • Dependent on a cane or walker
  • Use of anti-coagulants
  • Unwillingness to undergo a muscle biopsy
  • Taking prescription vitamin D2 or OCT vitamin D3 supplements of > 1000 IU/d
  • Inability or contraindications to consume daily vitamin D and calcium supplements
  • Weight loss of ≥ 5% or more in the past 6 months
  • Involved in any other intervention

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

16 participants in 2 patient groups

Calcium only
Active Comparator group
Description:
1200 mg Calcium per day
Treatment:
Dietary Supplement: calcium
Vitamin D plus calcium
Experimental group
Description:
2000 IU vitamin D plus 1200 mg calcium per day
Treatment:
Dietary Supplement: Vitamin D plus calcium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems